TRIMEDX is leading the industry with our proven clinical engineering expertise, coupled with over 25 years of medical device data and our state-of-the-art technology ecosystem, to transform clinical assets into a strategic lever for your health system. Through our core offering we uncover previously hidden insights to: • support clinical asset planning • maximize ROI • ensure equipment availability, compliance, and safety • ensure the safety and security of your connected medical devices Our dedicated, centralized support models deliver world-class quality, regulatory, supply chain and IT services that focus solely on the delivery of clinical engineering and clinical asset management services. Our multitude of data sources are aggregated into the TRIMEDX Clinical Asset Informatics platform that delivers actionable insights at your fingertips. The TRIMEDX proven methodology consistently delivers immediate savings of 10-20% and persistent savings of an average of 10% less than market price through long-term optimization of clinical asset inventories.

As the largest independent, technology-enabled clinical asset management company in the United States, TRIMEDX provides strategic planning and management of clinical assets to drive operational cost savings, free up capital for new strategic initiatives and deliver improved risk management and cyber protection.

Based in New York City, Aetion (pronounced eh-tee-ahn) is a leading healthcare technology company that delivers the real-world analytics and evidence needed for value-based care. With its patented rapid-cycle analytics™ technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in patient care. The company is backed by Flare Capital Partners, Lakestar, Oxeon Ventures and other leading individual health technology investors. Learn more at www.aetion.com.

Based in New York City, Aetion (pronounced eh-tee-ahn) is a leading healthcare technology company that delivers the real-world analytics and evidence needed for value-based care. With its patented rapid-cycle analytics™ technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in patient care. The company is backed by Flare Capital Partners, Lakestar, Oxeon Ventures and other leading individual health technology investors. Learn more at www.aetion.com.